X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5) 5
mutation (5) 5
genetic aspects (4) 4
humans (4) 4
animals (3) 3
asbestos exposure (3) 3
cancer (3) 3
cell line, tumor (3) 3
health aspects (3) 3
kinases (3) 3
mesothelioma (3) 3
adult (2) 2
aged (2) 2
alleles (2) 2
bap1 (2) 2
breast cancer (2) 2
breast neoplasms - genetics (2) 2
breast-cancer (2) 2
cell survival - drug effects (2) 2
chek2 (2) 2
chromosomes (2) 2
disease susceptibility (2) 2
female (2) 2
genes (2) 2
health risk assessment (2) 2
hereditary (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - genetics (2) 2
medicine (2) 2
mesothelioma - drug therapy (2) 2
mesothelioma - genetics (2) 2
mice (2) 2
middle aged (2) 2
multidisciplinary sciences (2) 2
mutations (2) 2
oncology (2) 2
palb2 (2) 2
pleural mesothelioma (2) 2
proteins (2) 2
rna, messenger - genetics (2) 2
akt protein (1) 1
albumin (1) 1
albumins - genetics (1) 1
albumins - metabolism (1) 1
aldosterone (1) 1
aldosterone - pharmacology (1) 1
alpha-fetoprotein (1) 1
aneuploidy (1) 1
antibodies (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor agents (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
apoptosis-inducing factor (1) 1
article (1) 1
asbestos (1) 1
atm (1) 1
b cells (1) 1
bap1 mutations (1) 1
bcl protein (1) 1
bcl-2 protein (1) 1
biochemistry & molecular biology (1) 1
biochemistry, genetics and molecular biology (1) 1
biological sciences (1) 1
brca1 (1) 1
brca1 protein (1) 1
brca2 (1) 1
breast (1) 1
breast neoplasms - epidemiology (1) 1
breast neoplasms - pathology (1) 1
cancer therapies (1) 1
capillaries (1) 1
care and treatment (1) 1
caspase (1) 1
caspase-3 (1) 1
cathepsin d (1) 1
cell activation (1) 1
cell biology (1) 1
cell cycle proteins - antagonists & inhibitors (1) 1
cell cycle proteins - genetics (1) 1
cell cycle proteins - metabolism (1) 1
cell death (1) 1
cell division (1) 1
cell fate (1) 1
cell growth (1) 1
cell proliferation - drug effects (1) 1
cell survival - genetics (1) 1
cell-lines (1) 1
cells, cultured (1) 1
cfi-402257 (1) 1
chromatin (1) 1
chromosomal instability (1) 1
chromosome deletion (1) 1
chromosomes, human, pair 3 - genetics (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clathrin (1) 1
comparative analysis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2016, Volume 113, Issue 47, pp. 13432 - 13437
Journal Article
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 03/2017, Volume 15, Issue 1, p. 58
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0124902
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 11/2017, Volume 36, Issue 46, pp. 6501 - 6507
Malignant mesothelioma (MM) is an aggressive malignancy, highly resistant to current medical and surgical therapies, whose tumor cells characteristically show... 
PROTEIN | PLEURAL MESOTHELIOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CHROMOSOMAL INSTABILITY | MURINE | CELL BIOLOGY | CFI-402257 | ANEUPLOIDY | ONCOLOGY | GENETICS & HEREDITY | ASBESTOS EXPOSURE | MUTATIONS | BAP1 | Lung Neoplasms - drug therapy | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | M Phase Cell Cycle Checkpoints - genetics | Cell Survival - genetics | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Cell Cycle Proteins - antagonists & inhibitors | Protein-Tyrosine Kinases - genetics | Neoplasms, Experimental - genetics | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Gene Expression Regulation, Neoplastic - drug effects | Protein-Serine-Threonine Kinases - metabolism | Pyrazoles - pharmacology | Lung Neoplasms - genetics | Cell Survival - drug effects | M Phase Cell Cycle Checkpoints - drug effects | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Mesothelioma - genetics | Pyrimidines - pharmacology | Mesothelioma - drug therapy | Protein Kinase Inhibitors - administration & dosage | Animals | Mesothelioma - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Survival Analysis | Cell Line, Tumor | Pemetrexed - administration & dosage | Mice, Inbred BALB C | Neoplasms, Experimental - metabolism | Neoplasms, Experimental - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Care and treatment | Enzyme inhibitors | Mesothelioma | Development and progression | Genetic aspects | Phosphotransferases | Health aspects | Cell fate | Tumor cells | Mitosis | Cell division | Aneuploidy | Malignancy | Kinases | Cancer therapies | Cisplatin | Genomic instability | TTK | genomic instability | Mps-1
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2016, Volume 113, Issue 47, p. 13432
  We used a custom-made comparative genomic hybridization array (aCGH; average probe interval 254 bp) to screen 33 malignant mesothelioma (MM) biopsies for... 
Chromatin | Sucrose | Genomics | Genes | Hybridization | Mutation | Chromosomes
Journal Article
Proceedings of the National Academy of Sciences, USA, ISSN 0027-8424, 11/2016, Volume 113, Issue 47, pp. 13432 - 13432
We used a custom-made comparative genomic hybridization array (aCGH; average probe interval 254 bp) to screen 33 malignant mesothelioma (MM) biopsies for... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.